NDZEMBANTEH ABOUBAKARY NULAMBEH – Pharmacogenomics – Best Researcher Award

Published on by Top Pharmaceutical

NDZEMBANTEH ABOUBAKARY NULAMBEH - Pharmacogenomics - Best Researcher Award

The University of Bamenda - Cameroon

INTRODUCTION

NDZEMBANTEH ABOUBAKARY NULAMBEH is a seasoned economist with a strong academic and professional background spanning over eight years. Based in Buea and Douala, Cameroon, he has a proven track record in teaching, research, and consultancy in economics. With expertise in quantitative and qualitative research methods, he has contributed significantly to the fields of sustainable finance, renewable energy, poverty and inequality, climate neutrality, and Islamic banking and finance. His academic journey is marked by achievements from prestigious institutions in Cameroon, Malaysia, and Turkey.

ACADEMIC AND PROFESSIONAL CAREER

Dr. Nulambeh earned his PhD in International Economics from Bursa Uludag University, Turkey, where he conducted groundbreaking research on sustainable development. He also holds a Master of Science in Economics from the International Islamic University of Malaysia and a Bachelor of Science in Economics from the University of Yaounde 2, Soa, Cameroon. He has served as an Assistant Lecturer at the Higher Institute of Management Studies and ISTGAC Maaron University Institute in Cameroon since 2021. Previously, he was an Assistant Professor at UNITAR International University in Malaysia, where he excelled in curriculum development and teaching.

RESEARCH CONTRIBUTIONS AND PUBLICATIONS

Dr. Nulambeh's research portfolio includes influential publications that explore the intersections of finance, economics, and environmental sustainability. His works address critical issues such as the energy-environment growth nexus, financial development, and the environmental Kuznets curve in African contexts. Notable publications include studies on the role of human capital and innovation in economic growth and the impact of foreign direct investment on trade openness. His research is featured in high-impact journals, reflecting his dedication to advancing economic knowledge.

CONFERENCES AND SEMINARS

Dr. Nulambeh actively participates in international conferences and seminars, presenting his research to global audiences. He has delivered insights on environmental quality, sustainable finance, and inclusive growth at events such as the Istanbul Finance Conference and Uludag University’s International Conference of Economics and Business. These engagements demonstrate his commitment to fostering academic discourse and influencing policy frameworks.

SKILLS AND TEACHING EXPERTISE

Dr. Nulambeh's extensive teaching experience spans applied econometrics, statistics, mathematical economics, and Islamic finance. His mastery of tools like SPSS, Eviews, Stata, and R complements his pedagogical expertise. Known for his superb classroom organization and mentorship skills, he has been instrumental in shaping the academic and professional trajectories of his students.

CONCLUSION

Dr. Nulambeh is a forward-thinking economist dedicated to addressing contemporary global challenges through innovative research and education. His focus on sustainable finance, green growth, and climate neutrality underscores his commitment to a future of inclusive and equitable development. He continues to inspire through his teaching, publications, and contributions to economic research and policy-making.

NOTABLE PUBLICATION

Foreign direct investment, trade openness and economic growth: A panel data analysis for sub-Saharan Africa 2018 (24)

The impact of human capital and innovation output on economic growth: comparative analysis of Malaysia and Turkey 2020 (15)

Exports, Imports, Exchange rates, Gross domestic investment, and Growth: Empirical Evidence from Cameroon 2016 (15)\

Exploring the energy-environment growth nexus in francophone Africa in presence of institutions 2022 (2)

Factors Contributing to the Acceptance of Verify Halal App Among the Malaysian Muslim Consumers 2024

Dr. ANTHOULA LAZARIS| Precision Medicine|Best Researcher Award

Published on by Top Pharmaceutical

Dr. ANTHOULA LAZARIS, Precision Medicine,Best Researcher Award

Dr. ANTHOULA LAZARIS, at MCGILL UNIV. HEALTH CTR,Canada

PROFILE

scopus

📚 Early Academic Pursuits :

Anthoula Lazaris began her academic journey with a B.Sc. in Microbiology and Immunology from McGill University (1983-1986), where she developed a solid foundation in the biological sciences. She continued at McGill, earning a Ph.D. in Biochemistry from the Faculty of Medicine (1988-1992). Her postdoctoral studies took her to Leiden, The Netherlands, where she further honed her expertise in Medical Biochemistry (1992-1994). This robust educational background laid the groundwork for her illustrious career in academia and biotechnology.

🏢Professional Endeavors :

Lazaris has accumulated over 30 years of combined experience in academia and industry, holding management and senior-level positions. Currently, she is a scientist at the Research Institute of the McGill University Health Centre (RI-MUHC), focusing on metastatic and metabolic diseases with an emphasis on translational research. Her career highlights include:

  • Liver Disease Biobank: In 2011, Lazaris established a Liver Disease Biobank in collaboration with Dr. P Metrakos, collecting biospecimens from patients with liver-related diseases.
  • Quebec Extracellular Vesicle Consortium: She spearheaded this consortium with Drs. Rak and Olivier, demonstrating her leadership in collaborative research initiatives.
  • CIHR Training Grant: Lazaris co-wrote and secured a substantial CIHR training grant for the Goodman Cancer Centre, illustrating her proficiency in obtaining competitive funding.

🔬Contributions and Research Focus :

Lazaris’s research contributions span several critical areas:

  • Metastatic Disease: She focuses on colorectal cancer liver metastases (CRCLM), investigating molecular mechanisms to predict therapeutic responses and developing new biomarkers.
  • Translational Research: Her work bridges basic and clinical research, aiming to translate findings into precision therapies for cancer patients. Notably, her research on predictors of therapeutic responses to antiangiogenic agents has been groundbreaking.
  • Liver Diseases: Lazaris’s research also covers hepatocellular carcinoma, cholangiocarcinomas, and NAFLD/NASH, contributing to the broader understanding of these conditions.

🏆Accolades and Recognition :

Throughout her career, Lazaris has received numerous accolades:

  • Scientific American Award: In 2002, she was recognized in the category of Research Leader in Chemical and Materials for her work on transgenic animals producing spider silk.
  • Genome Canada White Paper: She spearheaded the writing of a white paper on “Disease Mechanisms,” which was integrated into Genome Quebec’s strategic plan.
  • Scientific Publications: Her research has been published in prestigious journals like Nature and Science, highlighting her contributions to molecular biology and oncology.

🌍Impact and Influence :

Lazaris’s work has had a profound impact on both the scientific community and public health:

  • Innovations in Biotechnology: She was part of the team that demonstrated the first expression of soluble spider silk, which can be spun into fibers with remarkable mechanical properties.
  • Transgenic Research Network: As the Executive Director of the Quebec Transgenic Research Network, Lazaris unified the capabilities of researchers across Quebec, securing significant funding and fostering collaborative research.
  • Cloned Animals: She was part of the team that generated the world’s first cloned goat and Canada’s first large transgenic animal, showcasing her pioneering contributions to genetic engineering.

🌟Legacy and Future Contributions :

Anthoula Lazaris’s legacy is marked by her pioneering research, leadership in collaborative scientific endeavors, and significant contributions to translational medicine. Her work continues to influence the fields of molecular biology, biotechnology, and cancer research. Looking forward, Lazaris is expected to further her contributions to personalized medicine, leveraging her extensive experience and innovative approach to address pressing challenges in healthcare. Her dedication to translational research and collaborative spirit ensures that her impact will be felt for years to come.

🎓Publication 

Predictive biomarker discovery in cancer using a unique AI model based on set theory

Hepatic stellate cell stearoyl co-A desaturase activates leukotriene B4 receptor 2 – β-catenin cascade to promote liver tumorigenesis

    • Authors :Sinha, S., Aizawa, S., Nakano, Y., … Guccione, E., Tsukamoto, H.
    • Journal   :Nature Communications
    • Year       : 2023

Targeting Liver Metastases to Potentiate Immunotherapy in MS-Stable Colorectal Cancer—A Review of the Literature

  • Authors  :, Zlotnik, O., Krzywon, L., Bloom, J., … Lazaris, A., Metrakos, P.
  • Journal    :Cancers
  • Year         :  2023

Isolation of extracellular vesicles from human plasma samples: The importance of controls

  • Authors  :Tsamchoe, M., Petrillo, S., Lazaris, A., Metrakos, P.
  • Journal   : Biotechnology Journal
  • Year        :   2023

A Retrospective Study on the Role of Metformin in Colorectal Cancer Liver Metastases

  • Authors  :Rada, M., Krzywon, L., Petrillo, S., Lazaris, A., Metrakos, P.
  • Journal   : Biotechnology 
  • Year        :  2023